| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |